HomeOMCL • NASDAQ
Omnicell Inc
add
$28.08
2.26%
After Hours:(0.00%)0.00
$28.08
Closed: May 15, 4:18:42 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 269.67M | 9.55% |
Operating expense | 122.56M | 7.50% |
Net income | -7.02M | 55.20% |
Net profit margin | -2.60 | 59.18% |
Earnings per share | 0.26 | 766.67% |
EBITDA | 2.68M | 164.78% |
Effective tax rate | 26.31% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 386.83M | -24.50% |
Total assets | 2.15B | -5.79% |
Total liabilities | 894.37M | -18.33% |
Total equity | 1.26B | — |
Shares outstanding | 46.84M | — |
Price to book | 1.07 | — |
Return on assets | -1.36% | — |
Return on capital | -1.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.02M | 55.20% |
Cash from operations | 25.92M | -48.10% |
Cash from investing | -15.74M | -27.54% |
Cash from financing | 4.04M | -66.14% |
Net change in cash | 15.79M | -67.77% |
Free cash flow | 13.91M | -64.01% |
Previous close
$28.73
Day range
$27.98 - $29.10
Year range
$22.66 - $55.75
Market cap
1.32B USD
Avg Volume
764.19K
P/E ratio
62.11
Dividend yield
-
Primary exchange
NASDAQ
About
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia
Founded
Sep 1992
Headquarters
Website
Employees
3,620
